<DOC>
	<DOCNO>NCT00158379</DOCNO>
	<brief_summary>Time progression ( physical examination radiologic imaging</brief_summary>
	<brief_title>Taxol Carboplatin Erythropoetin</brief_title>
	<detailed_description />
	<mesh_term>Ovarian Neoplasms</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<criteria>patient primary ovarian cancer ECOG 02 Age &gt; = 18 chemotherapy , radiation immunotherapy medical history ovarian cancer adequate bone marrow , liver kidney reserve : leukocytes ≥ 2.0 x 109/l , platelet ≥ 100 x 109/l , bilirubin &lt; = 2,0 mg % , creatinine &lt; = 1,5 mg % creatinine clearance ≥ 60 ml/ min , hemoglobin ≥ 9 g/ dl SGOT , SGPT AP within 3 fold reference laboratory 's normal range write informed consent beforeexisting heart illness , Cardiac infarct within last 6 month Radiotherapy within 4 week study entry Patients pregnancy breast feeding ( premenopausal woman anticonception assure : intrauterine device , surgical method sterilization , , hormone insensitive tumor , oral , subcutaneous transvaginal hormonal , nonestrogen contain contraceptive )</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>